The latest study on Molecular Diagnostics and NAT Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Molecular Diagnostics and NAT Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Molecular Diagnostics and NAT and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Roche
Abbott
BD
Biomerieux
Qiagen
Thermo Fisher Scientific
Agilent
GenMark
Siemens Healthcare
AutoGenomics
Molecular Diagnostics and NAT Market Analysis By Type Segment:
Amplification Technologies
Amplified Gene Detection Technologies
DNA And Oligonucleotide Microarrays
Gene Sequencing
Molecular Diagnostics and NAT Market Analysis By Application Segment:
Hospitals and Clinics
Research Institutes
Diagnostic Centers
Molecular Diagnostics and NAT Market Analysis By Regions (Countries):
The Molecular Diagnostics and NAT Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Molecular Diagnostics and NAT Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Molecular Diagnostics and NAT Market:
Molecular Diagnostics and NAT market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Molecular Diagnostics and NAT Market status and future forecast.
To present the key Molecular Diagnostics and NAT Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Molecular Diagnostics and NAT Market Size Growth Rate by Type (2016-2027)
1.4.2 Amplification Technologies
1.4.3 Amplified Gene Detection Technologies
1.4.4 DNA And Oligonucleotide Microarrays
1.4.5 Gene Sequencing
1.5 Market by Application
1.5.1 Global Molecular Diagnostics and NAT Market Share by Application (2016-2027)
1.5.2 Hospitals and Clinics
1.5.3 Research Institutes
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Molecular Diagnostics and NAT Market Size
2.2 Molecular Diagnostics and NAT Growth Trends by Regions
2.2.1 Molecular Diagnostics and NAT Market Size by Regions (2016-2027)
2.2.2 Molecular Diagnostics and NAT Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Molecular Diagnostics and NAT Market Size by Manufacturers
3.1.1 Global Molecular Diagnostics and NAT Revenue by Manufacturers (2020)
3.1.2 Global Molecular Diagnostics and NAT Revenue Market Share by Manufacturers (2020)
3.1.3 Global Molecular Diagnostics and NAT Market Concentration Ratio (CR5 and HHI)
3.2 Molecular Diagnostics and NAT Key Players Head office and Area Served
3.3 Key Players Molecular Diagnostics and NAT Product/Solution/Service
3.4 Date of Enter into Molecular Diagnostics and NAT Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Molecular Diagnostics and NAT Market Size by Type (2016-2020)
4.2 Global Molecular Diagnostics and NAT Market Size by Application (2016-2020)
5 United States
5.1 United States Molecular Diagnostics and NAT Market Size (2016-2020)
5.2 Molecular Diagnostics and NAT Key Players in United States
5.3 United States Molecular Diagnostics and NAT Market Size by Type
5.4 United States Molecular Diagnostics and NAT Market Size by Application
6 Europe
6.1 Europe Molecular Diagnostics and NAT Market Size (2016-2020)
6.2 Molecular Diagnostics and NAT Key Players in Europe
6.3 Europe Molecular Diagnostics and NAT Market Size by Type
6.4 Europe Molecular Diagnostics and NAT Market Size by Application
7 China
7.1 China Molecular Diagnostics and NAT Market Size (2016-2020)
7.2 Molecular Diagnostics and NAT Key Players in China
7.3 China Molecular Diagnostics and NAT Market Size by Type
7.4 China Molecular Diagnostics and NAT Market Size by Application
8 Japan
8.1 Japan Molecular Diagnostics and NAT Market Size (2016-2020)
8.2 Molecular Diagnostics and NAT Key Players in Japan
8.3 Japan Molecular Diagnostics and NAT Market Size by Type
8.4 Japan Molecular Diagnostics and NAT Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Molecular Diagnostics and NAT Market Size (2016-2020)
9.2 Molecular Diagnostics and NAT Key Players in Southeast Asia
9.3 Southeast Asia Molecular Diagnostics and NAT Market Size by Type
9.4 Southeast Asia Molecular Diagnostics and NAT Market Size by Application
10 India
10.1 India Molecular Diagnostics and NAT Market Size (2016-2020)
10.2 Molecular Diagnostics and NAT Key Players in India
10.3 India Molecular Diagnostics and NAT Market Size by Type
10.4 India Molecular Diagnostics and NAT Market Size by Application
11 Central & South America
11.1 Central & South America Molecular Diagnostics and NAT Market Size (2016-2020)
11.2 Molecular Diagnostics and NAT Key Players in Central & South America
11.3 Central & South America Molecular Diagnostics and NAT Market Size by Type
11.4 Central & South America Molecular Diagnostics and NAT Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Molecular Diagnostics and NAT Introduction
12.1.4 Roche Revenue in Molecular Diagnostics and NAT Business (2020)
12.1.5 Roche Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Molecular Diagnostics and NAT Introduction
12.2.4 Abbott Revenue in Molecular Diagnostics and NAT Business (2020)
12.2.5 Abbott Recent Development
12.3 BD
12.3.1 BD Company Details
12.3.2 Company Description and Business Overview
12.3.3 Molecular Diagnostics and NAT Introduction
12.3.4 BD Revenue in Molecular Diagnostics and NAT Business (2020)
12.3.5 BD Recent Development
12.4 Biomerieux
12.4.1 Biomerieux Company Details
12.4.2 Company Description and Business Overview
12.4.3 Molecular Diagnostics and NAT Introduction
12.4.4 Biomerieux Revenue in Molecular Diagnostics and NAT Business (2020)
12.4.5 Biomerieux Recent Development
12.5 Qiagen
12.5.1 Qiagen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Molecular Diagnostics and NAT Introduction
12.5.4 Qiagen Revenue in Molecular Diagnostics and NAT Business (2020)
12.5.5 Qiagen Recent Development
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 Molecular Diagnostics and NAT Introduction
12.6.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2020)
12.6.5 Thermo Fisher Scientific Recent Development
12.7 Agilent
12.7.1 Agilent Company Details
12.7.2 Company Description and Business Overview
12.7.3 Molecular Diagnostics and NAT Introduction
12.7.4 Agilent Revenue in Molecular Diagnostics and NAT Business (2020)
12.7.5 Agilent Recent Development
12.8 GenMark
12.8.1 GenMark Company Details
12.8.2 Company Description and Business Overview
12.8.3 Molecular Diagnostics and NAT Introduction
12.8.4 GenMark Revenue in Molecular Diagnostics and NAT Business (2020)
12.8.5 GenMark Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Details
12.9.2 Company Description and Business Overview
12.9.3 Molecular Diagnostics and NAT Introduction
12.9.4 Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2020)
12.9.5 Siemens Healthcare Recent Development
12.10 AutoGenomics
12.10.1 AutoGenomics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Molecular Diagnostics and NAT Introduction
12.10.4 AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2020)
12.10.5 AutoGenomics Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Molecular Diagnostics and NAT Key Market Segments
Table Key Players Molecular Diagnostics and NAT Covered
Table Global Molecular Diagnostics and NAT Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type 2016-2027
Figure Amplification Technologies Figures
Table Key Players of Amplification Technologies
Figure Amplified Gene Detection Technologies Figures
Table Key Players of Amplified Gene Detection Technologies
Figure DNA And Oligonucleotide Microarrays Figures
Table Key Players of DNA And Oligonucleotide Microarrays
Figure Gene Sequencing Figures
Table Key Players of Gene Sequencing
Table Global Molecular Diagnostics and NAT Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Research Institutes Case Studies
Figure Diagnostic Centers Case Studies
Figure Molecular Diagnostics and NAT Report Years Considered
Table Global Molecular Diagnostics and NAT Market Size 2016-2027 (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Molecular Diagnostics and NAT Market Size by Regions 2016-2027 (Million US$)
Table Global Molecular Diagnostics and NAT Market Size by Regions 2016-2020 (Million US$)
Table Global Molecular Diagnostics and NAT Market Share by Regions 2016-2020
Figure Global Molecular Diagnostics and NAT Market Share by Regions 2016-2020
Figure Global Molecular Diagnostics and NAT Market Share by Regions 2020
Table Market Top Trends
Table Global Molecular Diagnostics and NAT Revenue by Manufacturers (2020) (Million US$)
Table Global Molecular Diagnostics and NAT Market Share by Manufacturers (2020)
Figure Global Molecular Diagnostics and NAT Market Share by Manufacturers in 2020
Table Global Molecular Diagnostics and NAT Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Molecular Diagnostics and NAT Product/Solution/Service
Table Date of Enter into Molecular Diagnostics and NAT Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table Global Molecular Diagnostics and NAT Market Size Share by Type (2016-2020)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Type (2016-2020)
Table Global Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table Global Molecular Diagnostics and NAT Market Size Share by Application (2016-2020)
Figure Global Molecular Diagnostics and NAT Market Size Market Share by Application (2016-2020)
Figure Global Molecular Diagnostics and NAT Revenue Market Share by Application in 2020
Figure United States Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table United States Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table United States Key Players Molecular Diagnostics and NAT Market Share (2020)
Table United States Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table United States Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table United States Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table United States Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure Europe Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table Europe Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table Europe Key Players Molecular Diagnostics and NAT Market Share (2020)
Table Europe Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table Europe Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table Europe Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table Europe Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure China Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table China Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table China Key Players Molecular Diagnostics and NAT Market Share (2020)
Table China Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table China Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table China Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table China Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure Japan Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table Japan Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table Japan Key Players Molecular Diagnostics and NAT Market Share (2020)
Table Japan Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table Japan Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table Japan Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table Japan Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure Southeast Asia Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table Southeast Asia Key Players Molecular Diagnostics and NAT Market Share (2020)
Table Southeast Asia Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table Southeast Asia Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure India Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table India Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table India Key Players Molecular Diagnostics and NAT Market Share (2020)
Table India Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table India Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table India Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table India Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Figure Central & South America Molecular Diagnostics and NAT Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Molecular Diagnostics and NAT Revenue (2020) (Million US$)
Table Central & South America Key Players Molecular Diagnostics and NAT Market Share (2020)
Table Central & South America Molecular Diagnostics and NAT Market Size by Type (2016-2020) (Million US$)
Table Central & South America Molecular Diagnostics and NAT Market Share by Type (2016-2020)
Table Central & South America Molecular Diagnostics and NAT Market Size by Application (2016-2020) (Million US$)
Table Central & South America Molecular Diagnostics and NAT Market Share by Application (2016-2020)
Table Roche Company Details
Table Roche Revenue in Molecular Diagnostics and NAT Business (2020) (Million US$)
Figure Roche Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Roche Recent Development
Table Abbott Company Details
Table Abbott Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Abbott Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Abbott Recent Development
Table BD Company Details
Table BD Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure BD Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table BD Recent Development
Table Biomerieux Company Details
Table Biomerieux Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Biomerieux Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Biomerieux Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Qiagen Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Qiagen Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Thermo Fisher Scientific Recent Development
Table Agilent Company Details
Table Agilent Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Agilent Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Agilent Recent Development
Table GenMark Company Details
Table GenMark Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure GenMark Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table GenMark Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table Siemens Healthcare Recent Development
Table AutoGenomics Company Details
Table AutoGenomics Revenue in Molecular Diagnostics and NAT Business (2020)(Million US$)
Figure AutoGenomics Revenue Growth Rate in Molecular Diagnostics and NAT Business (2020)
Table AutoGenomics Recent Development
Table Global Molecular Diagnostics and NAT Market Size by Regions (Million US$) 2021-2027
Figure Global Molecular Diagnostics and NAT Market Size Share by Regions (2021-2027)
Figure Global Molecular Diagnostics and NAT Market Size Share by Regions in 2027
Figure United States Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure Europe Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure China Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure Japan Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure India Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Molecular Diagnostics and NAT Market Size Forecast (2021-2027)(Million USD)
Table Global Molecular Diagnostics and NAT Market Size by Product (2021-2027) (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size by Product (2021-2027)
Figure Global Molecular Diagnostics and NAT Market Size by Product in 2027
Table Global Molecular Diagnostics and NAT Market Size by Application (2021-2027) (Million US$)
Figure Global Molecular Diagnostics and NAT Market Size by Application (2021-2027)
Figure Global Molecular Diagnostics and NAT Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources